AARHUS, DENMARK, 23 June 2025: Cercare Medical is proud to announce its successful selection
in the Norwegian National Tender for advanced imaging software. This award secures Cercare Medical’s installation across
every public hospital in Norway, enabling national-scale diagnostic excellence in
stroke and oncology.
With over
60 installations planned and support for
thousands of CT and MRI scans annually, this
national rollout marks a major milestone in the adoption of next-generation perfusion imaging. The
deployment integrates seamlessly with multiple
leading PACS platforms, ensuring clinicians can
access Cercare’s biomarkers and maps directly within existing workflows.
In Collaboration with Deepc
To realize this ambitious deployment, Cercare Medical will work closely with its strategic partner
Deepc, a German-based AI orchestration platform provider.
Deepc’s role is to ensure centralized AI integration, governance, and monitoring across all sites. Their platform provides the interoperability and scalability needed to deliver Cercare Medical’s high
performance post-processing tools in a secure and unified environment.
Cercare Medical provides the clinical intelligence layer, with fully automated CT and MRI perfusion
post-processing. Its vendor-neutral software supports quantitative biomarkers that enhance
decision-making in time-critical cases, including acute ischemic stroke and oncology diagnostics.
Together, the Cercare-Deepc partnership brings national health systems an integrated, intelligent,
and compliant AI infrastructure—delivering clinical value without disrupting radiology workflows.
Supporting Better Patient Outcomes Across Norway
Through this initiative, the entire Norwegian population will now benefit from cutting-edge imaging tools designed to improve diagnosis, triage, and treatment planning for both acute and chronic neurological conditions.
“This national rollout is a reflection of the trust placed in our technology and the clinical value it
delivers. We are honored to support the Norwegian healthcare system and proud to collaborate with Deepc to make AI-powered imaging more accessible, scalable, and impactful,” said Henrik Andersen, Chief Commercial Officer at Cercare Medical.
A Strategic Reference for Global Expansion
The Norwegian deployment marks another significant milestone for Cercare Medical, bringing the
company’s global footprint to over 100 installations across 23 countries, supporting more than 1.2
million diagnoses annually. As a national reference site, Norway exemplifies how fully integrated AI
and imaging solutions can be deployed at scale—demonstrating Cercare Medical’s ability to
combine clinical precision, operational reliability, and health system compliance. This
achievement further positions the company for accelerated growth across Europe, Asia, and North
America.
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and
multi-vendor compatible software for CT and MRI perfusion imaging post-processing, we are committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.
